Literature DB >> 12243049

[Anti-arrhythmic drug therapy in impaired liver function].

C Perings1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12243049     DOI： 10.1007/s00108-002-0694-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  7 in total

1.  Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.

Authors:  A Capucci; G Q Villani; D Aschieri; A Rosi; M F Piepoli
Journal:  Eur Heart J       Date:  2000-01       Impact factor: 29.983

Review 2.  [Atrial fibrillation].

Authors:  M G Hennersdorf; C Perings; M Kelm; B E Strauer
Journal:  Internist (Berl)       Date:  2001-12       Impact factor: 0.743

3.  Does ursodeoxycholic acid have a place in the treatment of amiodarone-induced cholestasis?

Authors:  R Reshef; I Cohen; M Shiller; S Szvalb; N Loberant
Journal:  J Clin Gastroenterol       Date:  1994-03       Impact factor: 3.062

4.  Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients.

Authors:  J H Lewis; R C Ranard; A Caruso; L K Jackson; F Mullick; K G Ishak; L B Seeff; H J Zimmerman
Journal:  Hepatology       Date:  1989-05       Impact factor: 17.425

5.  Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.

Authors:  D Roy; M Talajic; P Dorian; S Connolly; M J Eisenberg; M Green; T Kus; J Lambert; M Dubuc; P Gagné; S Nattel; B Thibault
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

6.  Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction.

Authors:  O D Pedersen; H Bagger; L Kober; C Torp-Pedersen
Journal:  Circulation       Date:  1999-07-27       Impact factor: 29.690

7.  The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.

Authors:  E E Powell; W G Cooksley; R Hanson; J Searle; J W Halliday; L W Powell
Journal:  Hepatology       Date:  1990-01       Impact factor: 17.425
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.